Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects

Clinical trial NCT05938452 · COMPLETED

Trial details

NCT number: NCT05938452
Sponsor: Forest Hills Lab
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neurological Disorder

Start date: 2022-12-12
Primary completion: 2023-10-19
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.